-
-
-
-
-
-
-
Myriad Genetics provides 2025 preliminary results and 2026 guidance
-
-
-
-
-
-
-
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Tops Q1 EPS by 3c ; Offers Guidance
-
-
-
-
-
-
-
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
-
-
-
-
-
-
-
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Announces CFO Resignation
-
1,199,633 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

